Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Or Gozani

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Nature|July 1, 2026
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Nature Communications|May 4, 2021
DNMT1 reads heterochromatic H4K20me3 to reinforce LINE-1 DNA methylationWendan Ren, Huitao Fan, Sara A Grimm, et al.
Nature|November 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 4, 2021
Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotypePaolo Zanoni, Katharina Steindl, Deepanwita Sengupta, et al.
Molecular Cell|October 3, 2025
A needed nomenclature for nucleosomesMichael-Christopher Keogh, Genevieve Almouzni, Andrew J Andrews, et al.
Nature|August 6, 2025
NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancersJinho Jeong, Simone Hausmann, Hanyang Dong, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Nature|July 1, 2026
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Nature Communications|May 4, 2021
DNMT1 reads heterochromatic H4K20me3 to reinforce LINE-1 DNA methylationWendan Ren, Huitao Fan, Sara A Grimm, et al.
Nature|November 26, 2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancerJia J Li, Alessandro Vasciaveo, Dimitris Karagiannis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 4, 2021
Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotypePaolo Zanoni, Katharina Steindl, Deepanwita Sengupta, et al.
Molecular Cell|October 3, 2025
A needed nomenclature for nucleosomesMichael-Christopher Keogh, Genevieve Almouzni, Andrew J Andrews, et al.
Nature|August 6, 2025
NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancersJinho Jeong, Simone Hausmann, Hanyang Dong, et al.
Pageof 12